« Return to News | CROs/Service Providers

ClinPhone Inks Deal with Japanese Pharma

Friday, September 14, 2007 11:59 AM

eClinical technology company ClinPhone has secured a contract with Bayer Yakuhin, the Japanese affiliate of Bayer. ClinPhone has been named the company’s preferred supplier of randomization and trial supply management services, specifically using ClinPhone’s Interactive Voice Response System (IVRS) for a phase III trial in Japan. ClinPhone opened its Asia Pacific offices in Melbourne Australia in late 2006 and credits the move for helping land this new contract.

ClinPhone's director of business development for Asia Pacific expanded on the importance of having a physical presence in the region.

“This important project demonstrates our commitment to serving our clients in this region. The location of the offices in Melbourne means that ClinPhone is able to provide a more consultative service across the Asia Pacific. The availability of business, technical and operational expertise in Asian business hours will really complement our established 24/7 global service and enable us to focus on the needs of our customers as we continue to strengthen our presence in the region,” he stated.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.